In summary, all persons with ALS should be offered single‐step genetic testing, consisting of a C9orf72 assay, along with sequencing of SOD1, FUS, and TARDBP, at a minimum. This evidence concerns the gene C9orf72 and amyotrophic lateral sclerosis.